Resources from the same session
Introduction
Presenter: Byoung Cho
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
Navigating first-line treatment decisions for EGFRM+ NSCLC: Extrapolating from Asian clinical trial experience
Presenter: John Wen-Cheng Chang
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
Tackling Uncommon EGFR mutations: Efficacy of EGFR TKIs in NSCLC
Presenter: Hiroshi Tanaka
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
KRAS-mutant NSCLC treatment advances on the horizon
Presenter: Byoung Cho
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast
Live Q&A
Presenter: Hiroshi Tanaka
Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future
Resources:
Webcast